Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ovarian Neoplasms

  Free Subscription


17.09.2018

1 BMC Cancer
1 Clin Cancer Res
1 Eur J Obstet Gynecol Reprod Biol
4 Gynecol Oncol
1 Int J Gynaecol Obstet


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. FENG Z, Wen H, Ju X, Bi R, et al
    The preoperative prognostic nutritional index is a predictive and prognostic factor of high-grade serous ovarian cancer.
    BMC Cancer. 2018;18:883.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  2. MATUSZEWSKA K, Santry LA, Van Vloten JP, Au Yeung A, et al
    Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in Advanced Stage Ovarian Cancer.
    Clin Cancer Res. 2018 Sep 11. pii: 1078-0432.CCR-18-0220.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  3. TIMMERMANS M, Sonke GS, van Driel WJ, Lalisang RI, et al
    Neoadjuvant chemotherapy or primary debulking surgery in FIGO IIIC and IV patients; results from a survey study in the Netherlands.
    Eur J Obstet Gynecol Reprod Biol. 2018;223:98-102.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  4. AZIZ D, Etemadmoghadam D, Caldon CE, Au-Yeung G, et al
    19q12 amplified and non-amplified subsets of high grade serous ovarian cancer with overexpression of cyclin E1 differ in their molecular drivers and clinical outcomes.
    Gynecol Oncol. 2018 Sep 9. pii: S0090-8258(18)31169.
    PubMed     Text format     Abstract available

  5. ZHAO H, Yu H, Zheng J, Ning N, et al
    Lowly-expressed lncRNA GAS5 facilitates progression of ovarian cancer through targeting miR-196-5p and thereby regulating HOXA5.
    Gynecol Oncol. 2018 Sep 7. pii: S0090-8258(18)31162.
    PubMed     Text format     Abstract available

  6. CONNOR JP, O'Shea A, McCool K, Sampene E, et al
    Peri-operative allogeneic blood transfusion is associated with poor overall survival in advanced epithelial ovarian Cancer; potential impact of patient blood management on Cancer outcomes.
    Gynecol Oncol. 2018 Sep 7. pii: S0090-8258(18)31170.
    PubMed     Text format     Abstract available

  7. SCURRY J, van Zyl B, Gulliver D, Otton G, et al
    Nucleotide excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancer.
    Gynecol Oncol. 2018 Sep 4. pii: S0090-8258(18)31160.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  8. BOGANI G, Leone Roberti Maggiore U, Chiappa V, Ditto A, et al
    The addition of lymphadenectomy to secondary cytoreductive surgery in comparison with bulky node resection in patients with recurrent ovarian cancer.
    Int J Gynaecol Obstet. 2018 Sep 8. doi: 10.1002/ijgo.12667.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: